Updated 1/2014 Y0071_14_19077_I_002 01/06/2014 29264MUPENMUB_002 1 . Effect of aspirin on disability-free Survival in the healthy elderly. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel.
American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in Older adults. The update was published online January 29 in the Journal of the American Geriatrics Society. The 2019 update uses the five criteria outlined in 2015; these include medications that should typically be avoided in most older patients, medications that should be avoided in older patients with certain conditions, medications that should be used with caution because of benefits that may offset risks, medication interactions, and changes in dosing based on kidney function.
Study Synopsis and Perspective The American Geriatrics Society (AGS) has released the 2019 update to the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. • Avoid most antipsychotics in patients with Parkinson disease complicated by psychosis, although quetiapine, clozapine, and pimavanserin may be used with caution.• Avoid using rivaroxaban and dabigatran in older adults because of a higher bleeding risk than warfarin and other direct oral anticoagulants.• Avoid tramadol use because of the risk of hyponatremia from syndrome of inappropriate antidiuretic hormone secretion.• Avoid prescribing opioids with benzodiazepines or gabapentinoids because the combinations increase the risk of severe respiratory depression.The Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (i.e., at least 65 years of age), originally developed by Mark H. Beers in 1991, continue to be used by the American Geriatrics Society (AGS) to provide guidance regarding medications that should be avoided in most older patients or in certain situations. High Risk Medications in Older Adults: Drug Alternative(s) Drug Class Drug Names Concern / Risk1 Beers Recommendation1 The current document updates the Beers criteria for clinicians. …